A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 1,865 shares of ABBV stock, worth $337,826. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,865
Previous 1,854 0.59%
Holding current value
$337,826
Previous $317,000 16.09%
% of portfolio
0.08%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$163.84 - $199.33 $1,802 - $2,192
11 Added 0.59%
1,865 $368,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $2,167 - $2,530
14 Added 0.76%
1,854 $317,000
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $1,917 - $2,185
12 Added 0.66%
1,840 $335,000
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $25,043 - $28,204
182 Added 11.06%
1,828 $283,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $1,736 - $2,010
13 Added 0.8%
1,646 $245,000
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $1,590 - $1,978
12 Added 0.74%
1,633 $220,000
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $1,590 - $1,831
11 Added 0.68%
1,621 $258,000
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $10,096 - $12,108
-73 Reduced 4.34%
1,610 $260,000
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $7,113 - $8,158
53 Added 3.25%
1,683 $226,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $40,047 - $50,913
-291 Reduced 15.15%
1,630 $251,000
Q1 2022

Apr 08, 2022

SELL
$131.98 - $163.75 $16,233 - $20,141
-123 Reduced 6.02%
1,921 $311,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $1,289 - $1,631
12 Added 0.59%
2,044 $277,000
Q3 2021

Oct 13, 2021

BUY
$106.4 - $120.78 $10,320 - $11,715
97 Added 5.01%
2,032 $221,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $1,262 - $1,406
12 Added 0.62%
1,935 $217,000
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $1,329 - $1,464
13 Added 0.68%
1,923 $208,000
Q4 2020

Jan 22, 2021

BUY
$80.49 - $108.67 $153,735 - $207,559
1,910 New
1,910 $201,000
Q3 2020

Oct 13, 2020

SELL
$85.91 - $100.83 $187,713 - $220,313
-2,185 Closed
0 $0
Q2 2020

Jul 09, 2020

SELL
$73.37 - $98.18 $13,646 - $18,261
-186 Reduced 7.84%
2,185 $211,000
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $967 - $1,466
15 Added 0.64%
2,371 $200,000
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $169,938 - $212,629
2,356 New
2,356 $209,000
Q2 2019

Jul 17, 2019

SELL
$65.7 - $83.98 $174,236 - $222,714
-2,652 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$77.14 - $90.79 $539 - $635
7 Added 0.26%
2,652 $214,000
Q4 2018

Feb 01, 2019

BUY
$77.85 - $96.01 $5,293 - $6,528
68 Added 2.64%
2,645 $204,000
Q3 2018

Nov 16, 2018

BUY
$88.91 - $98.84 $26,850 - $29,849
302 Added 13.27%
2,577 $226,000
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $204,249 - $241,673
2,275 New
2,275 $211,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northwest Quadrant Wealth Management, LLC Portfolio

Follow Northwest Quadrant Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Quadrant Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Quadrant Wealth Management, LLC with notifications on news.